Open Access

[Corrigendum] PF‑2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells

  • Authors:
    • Chen Chen
    • Qinghua Zeng
    • Liang Luo
    • Chengzhi Cai
  • View Affiliations

  • Published online on: January 24, 2024     https://doi.org/10.3892/etm.2024.12399
  • Article Number: 111
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

March-2024
Volume 27 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen C, Zeng Q, Luo L and Cai C: [Corrigendum] PF‑2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells. Exp Ther Med 27: 111, 2024.
APA
Chen, C., Zeng, Q., Luo, L., & Cai, C. (2024). [Corrigendum] PF‑2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells. Experimental and Therapeutic Medicine, 27, 111. https://doi.org/10.3892/etm.2024.12399
MLA
Chen, C., Zeng, Q., Luo, L., Cai, C."[Corrigendum] PF‑2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells". Experimental and Therapeutic Medicine 27.3 (2024): 111.
Chicago
Chen, C., Zeng, Q., Luo, L., Cai, C."[Corrigendum] PF‑2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells". Experimental and Therapeutic Medicine 27, no. 3 (2024): 111. https://doi.org/10.3892/etm.2024.12399